Diabetes drug trial aims to sharpen minds in schizophrenia
NCT ID NCT05838573
Summary
This study is testing if metformin, a common diabetes medication, can improve thinking, memory, and brain function in people with schizophrenia. It will involve 120 participants who will take either metformin or a placebo pill for 24 weeks. Researchers will use brain scans and cognitive tests to see if the drug helps with the cognitive difficulties often associated with the condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mental Health Institute of Second Xiangya Hospital,CSU
RECRUITINGChangsha, Hunan, 410011, China
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shandong Mental Health Center
RECRUITINGJinan, Shandong, 250014, China
Contact Phone: •••-•••-••••
-
The Second People's Hospital of Dali Bai Autonomous Prefecture
RECRUITINGDali, Yunnan, 671014, China
Contact Phone: •••-•••-••••
-
The Third Peoples's Hospital of Jiangyin
RECRUITINGJiangyin, Jiangsu, 214400, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.